CareTria

Overview

CareTria is an integrated therapy initiation hub combining provider-embedded digital enrollment, automated benefit verification (powered by eBlu), national sample management, owned specialty pharmacy, and 3PL fulfillment under one operating model for manufacturer launch and access teams. CareTria is the current operating name for Knipper Health / J. Knipper and Company, rebranded in 2026 after acquiring eBlu Solutions; buyers searching KnipperRx, KnippeRx, Knipper Health, or J. Knipper and Company should evaluate CareTria as the active entity, now backed by Frazier Healthcare Partners with ex-Cencora leadership (Willis Chandler, CEO).

CareTria is best read as a vertically integrated order-to-therapy operator — provider portal through dispensing — rather than as a pure-play hub services vendor, a sample-management point solution, or a logistics-only 3PL. The differentiator is the combination, not any single layer.

Hub Capability Model

The framework below standardizes how Rx Almanac evaluates hub-services capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, CareTria is evaluated as a vertically integrated therapy-initiation platform.

Capability	Buyer should compare	CareTria readout
Therapy initiation and enrollment intake	Digital and human intake, eConsent, missing-information resolution, provider/patient portals, and clean case creation.	Core intake workflow. Provider-embedded digital enrollment through a 100,000+ provider network, EMR-integrated via the eBlu Solutions acquisition; KnippeRx Cares ties intake to the rest of the operating stack.
Benefits verification and coverage triage	Medical/pharmacy benefit verification, eligibility checks, payer-policy lookup, coverage routing, and speed from referral to actionable case.	Core coverage workflow. eBlu-powered real-time benefit investigation with reported 85% automation in under 60 seconds; live across the 15,000-specialty-provider eBlu network.
Prior authorization, appeals, and reimbursement casework	PA initiation, payer-specific forms, clinical documentation, appeals, denial management, and field reimbursement handoffs.	PA casework. Electronic prior authorization workflows reduce administrative delays; confirm therapy-specific PA depth and field-reimbursement handoff in diligence.
Affordability, PAP, and copay operations	Copay, free-drug, bridge, foundation, income verification, PAP renewal, and gross-to-net sensitive affordability logic.	Affordability operations. PAP enrollment and management; one Top 15 PAP program scaled to 99K patients with a 66% reduction reported in published case studies.
Patient engagement and adherence operations	Omnichannel reminders, clinical education, nursing or training escalation, persistence outreach, and patient-facing support quality.	Engagement model. Omni-channel patient and HCP communication across phone, fax, SMS, email, digital engagement, and virtual patient training, supported by a 250-seat contact center.
Fulfillment, specialty pharmacy, and distribution coordination	Routing to SPs, non-commercial dispensing, DTP shipment, sample/replacement product, 3PL, and cold-chain handoffs.	Core fulfillment handoff. 800,000+ sq ft cGMP logistics across NJ, IN, FL, KY, with cold-chain capability; Samplicity is the largest integrated sample-management platform in the U.S.; Memphis TN cold-chain facility added via the Patheon Pharma Services carve-out (Dec 2024).
Program reporting, integrations, and governance	Manufacturer dashboards, KPI reporting, CRM/EHR/API integrations, SLA governance, and operating visibility across vendors.	Reporting layer. Real-time analytics and conversion tracking across the integrated stack; confirm cross-program reporting depth and integration with incumbent manufacturer CRM and data-lake environments.

Buyer Fit

• Evaluation trigger: Include CareTria when the launch needs coordinated therapy initiation, sample management, and fulfillment from a single operator rather than stitching three point solutions together.
• Best-fit buyers: Pharma manufacturers and biotech launch teams in specialty, biologics, and small-molecule launches across Oncology, Immunology/Autoimmune, Neurology, Gastroenterology, Dermatology, Ophthalmology, and Hematology.
• Less ideal fit: Programs that need a pure analytics or data platform, a payer-side UM tool, or a single high-touch hub-services contract with no fulfillment or sample-management scope.
• Commercial fit: Pricing is custom / RFP; scope should specify which capabilities are bundled (provider portal, eBlu BV, KnippeRx, Samplicity, specialty pharmacy, 3PL) and which are stood up program-by-program.
• Role diligence: Confirm staffing model, launch-surge plan, data-feed integration, and division of labor with partner specialty pharmacies for any LDD-network products.

Differentiators

• Vertically integrated therapy-initiation platform: Provider-embedded enrollment, automated benefit verification, sample management, specialty pharmacy, and 3PL fulfillment in one operating model — a combination no other hub services vendor currently matches.
• eBlu-powered real-time benefit verification: ~85% automated benefit investigation in under 60 seconds, live across a 15,000-specialty-provider network after the July 2025 eBlu Solutions acquisition.
• Samplicity sample-management platform: The largest integrated sample-management system in the U.S.; differentiator vs. hub-only competitors that lack a physical sample-distribution footprint.
• 800,000+ sq ft cGMP logistics footprint: Multi-state facilities (NJ, IN, FL, KY) with cold-chain capability; Memphis TN added Dec 2024 via the Patheon Pharma Services carve-out near the FedEx world hub.
• Ex-Cencora leadership + Frazier backing: Willis Chandler (CEO, ex-Cencora President of Global Pharma Services) and Frazier Healthcare Partners majority ownership set up CareTria as an independent alternative to wholesaler-owned hub stacks like Cencora Lash Group (now divested to CareMetx) and McKesson CoverMyMeds.

RFP Questions

• Which steps are performed by the vendor, by a partner specialty pharmacy, and by the manufacturer?
• What median time-to-therapy, PA turnaround, and first-fill conversion metrics can be reported by brand?
• How are benefit verification, PAP, copay, and adherence data reconciled into manufacturer dashboards?
• What launch-surge staffing, training, and bilingual coverage commitments are available in the first 90 days?

Recent Activity

• 2026-05 - Current CareTria materials reinforce the KnipperRx rebrand, CaryHealth acquisition, Provider Connect scale, and therapy-initiation platform model across enrollment, BV, samples, pharmacy, and 3PL.

• Mar 2024 - RxLightning partnership - co-branded provider portal for free-drug + PAP enrollment via KnippeRx.

• Dec 2024 - Patheon Pharma Services carve-out from Thermo Fisher Scientific - adds Memphis, TN cold-chain facility near FedEx world hub.

• Apr 2025 - Three new execs: Alexis Rose, Champ Burgess, Tony Martin (Chief Growth Officer, ex-Cencora).

• Jul 2025 - Willis Chandler appointed CEO (ex-Cencora President, Global Pharma Services).

• Jul 2025 - eBlu Solutions acquired - provider-embedded tech platform, 15,000 specialty providers.